Non-valvular Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Non-valvular Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Amplatzer Amulet China Post Market Study (PMS)
Post-market study results for Amplatzer Amulet in China in patients with non-valvular atrial fibrillation have been posted after termination…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination [NA]
A pivotal IDE study on laminar left atrial appendage elimination for non-valvular atrial fibrillation is currently suspended.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: WATCHMAN FLX Pro European Registry [NA]
The WATCHMAN FLX Pro European Registry is currently recruiting to study left atrial appendage closure in patients with non-valvular atrial f…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation [Phase 4]
This Phase 4 study evaluates the population pharmacokinetics of edoxaban in Chinese patients with non-valvular atrial fibrillation.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding
Clinical trial update describing a study that investigates the effects of interrupting anticoagulant therapy during percutaneous left atrial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: The CONFORMAL Early Feasibility Study [NA]
The CONFORMAL Early Feasibility Study by Conformal Medical is active but not recruiting, with the study targeting non-valvular atrial fibril…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke [NA]
This is a prospective, single-arm study evaluating the endothelialization effect and timeline of the AnchorMan Left Atrial Appendage Occlude…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Amplatzer Amulet China Post Market Study (PMS)
A post-market study of the Amplatzer Amulet in China sponsored by Abbott Medical Devices has been terminated.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Applause Study I - Append System Early Feasibility Study [NA]
Applause Study I is an early feasibility trial sponsored by Append Medical Ltd. for non-valvular atrial fibrillation, and is not yet recruit…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation
This clinical trial update describes an ongoing Italian study evaluating associations between patient characteristics and the use of oral an…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Watchman FLX Pro CT Pilot Study [NA]
A completed pilot clinical trial evaluating the Watchman FLX Pro CT device for non-valvular atrial fibrillation with results posted.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Evaluation of Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk [NA]
This clinical trial update notes the safety and performance evaluation of the Omega LAA Occluder and its Delivery System in patients with no…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: WATCHMAN FLX™ CT Study [NA]
This clinical trial update reports the completion of the WATCHMAN FLX CT Study evaluating left atrial appendage closure to reduce stroke and…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation
This clinical trial update reports the clinical and economic outcomes of oral anticoagulants in patients with non-valvular atrial fibrillati…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation
This entry notes an ongoing clinical trial assessing thromboembolic and bleeding risk stratification in patients with non-valvular atrial fi…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
This clinical trial is currently recruiting to evaluate stroke risk assessment and biomarkers of blood clotting in adults with newly diagnos…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation [Phase 4]
Phase 4 clinical trial update showing enrollment for a head-to-head comparison of apixaban versus rivaroxaban in non-valvular atrial fibrill…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
A real-world study evaluating edoxaban use in patients with non-valvular atrial fibrillation in China has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)
This completed study assessed the safety and effectiveness of rivaroxaban (Xarelto) for prevention of stroke and systemic embolism in Indian…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis
A completed clinical trial compares safety and effectiveness of warfarin versus apixaban in patients with end-stage kidney disease on dialys…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment
A completed observational trial update from Bayer describing an Italian study to quantify how many non-valvular atrial fibrillation patients…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: The Conformal Prague Study [NA]
Results from the Conformal Prague Study, sponsored by Conformal Medical, have been posted for non-valvular atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong
Clinical trial update indicating the WATCHMAN FLX left atrial appendage closure device was evaluated for safety and effectiveness in Hong Ko…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)
A Bayer-sponsored real-world study evaluating the safety and effectiveness of oral anticoagulants in patients with non-valvular atrial fibri…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban [NA]
A terminated clinical trial evaluating changes in coagulation activity in patients with non-valvular atrial fibrillation being treated with …